<DOC>
	<DOCNO>NCT02082236</DOCNO>
	<brief_summary>The purpose study establish single multiple-dose pharmacokinetics ( PK ) sublingual administration Sufentanil Sublingual Microtablet ( SSM ) 30 mcg compare pharmacokinetics single dose SSM 30 mcg 2 dos SSM 15 mcg administer 20 minute apart .</brief_summary>
	<brief_title>Pharmacokinetics Sufentanil Sublingual Microtablet 30 mcg 15 mcg Healthy Subjects</brief_title>
	<detailed_description />
	<mesh_term>Sufentanil</mesh_term>
	<criteria>1 . Nonsmoking male female subject 2 . Aged 18 45 year inclusive 3 . Subjects must Body Mass Index ( BMI ) 18 30 , inclusively . 1 . Subjects take overthecounter medication ( except single dose multivitamin supplement acetaminophen less 2 g/day ) within 14 day prior start sufentanil dose prescription medication counter ( OTC ) medication 2 . Female subject pregnant 3 . Subjects chronic obstructive pulmonary disease , sleep apnea , significant respiratory disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Plasma concentration</keyword>
</DOC>